Prices delayed by at least 15 minutes | Print
MacroGenics (MGNX)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 CTLA-4), Tebotelimab (PD-1 LAG-3), MGD024 (CD123 CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV CD3).
Address
9704 Medical Center Drive
Rockville
MD
USA
20850
Telephone
+1 301 251-5172
Forecast key dates
| Name | Key Date |
|---|---|
| Macrogenics Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-07T16:30:00 |
| Macrogenics Inc Fourth Quarter Earnings Results for 2024 | 2025-03-07T00:00:00 |
| Macrogenics Inc Annual Report for 2024 | 2025-03-07T00:00:00 |
| Macrogenics Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-06T16:30:00 |
| Macrogenics Inc Third Quarter Earnings Results for 2024 | 2024-11-06T00:00:00 |
| Macrogenics Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-09T16:30:00 |
| Macrogenics Inc Second Quarter Earnings Results for 2024 | 2024-08-09T00:00:00 |
| Macrogenics Inc Annual General Meeting for 2024 | 2024-05-31T09:00:00 |
| Macrogenics Inc First Quarter Earnings Conference Call for 2024 | 2024-05-09T16:30:00 |
| Macrogenics Inc First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.